Medical cannabis 'safe' for severe childhood epilepsy
UPDATED 17 August 2018
Australia's first trial into cannabidiol for children with severe epilepsy has deemed the treatment is safe, despite one in five participants experiencing a serious adverse event linked to the medication.
The 12-week NSW study of 40 children with drug-resistant disease and uncountable daily seizures shows more than half experienced at least some improvement on the cannabis extract Epidolex according to reports from carers.
None of the children, who were aged between 19 months and 16 years, became completely seizure free during the trial.